Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 31, 2023

Details for Patent: 7,232,572

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 7,232,572 protect, and when does it expire?

Patent 7,232,572 protects ORACEA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 7,232,572

Title:	Methods of treating rosacea
Abstract:	A method of treating rosacea in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat rosacea, but has substantially no antibiotic activity.
Inventor(s):	Ashley; Robert A. (Tucson, AZ)
Assignee:	CollaGenex Pharmaceuticals, Inc. (Newtown, PA)
Application Number:	11/061,866
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,232,572
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,232,572

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Galderma Labs Lp	ORACEA	doxycycline	CAPSULE;ORAL	050805-001	May 26, 2006		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,232,572

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	330615	⤷ Try a Trial
Australia	2002303250	⤷ Try a Trial
Canada	2440472	⤷ Try a Trial
Canada	2719162	⤷ Try a Trial
Germany	60212613	⤷ Try a Trial
Denmark	1383508	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Baxter

Harvard Business School

Johnson and Johnson

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.